Overview The Global Antisense and RNAi Therapeutics Market is expected to be valued USD 5.5 billion in 2024 and is anticipated to reach USD 27.2 billion by 2033 at a CAGR of 19.4%. The Antisense and RNAi therapeutics market represents a dynamic and rapidly evolving segment of the biotechnology industry. These therapies involve the use of synthetic nucleic acids to target and modulate gene...